strong>Hyatt Regency San Francisco [
clear filter]
arrow_back View All Dates
7:30am PST
7:30am PST
8:30am PST
Opening Remarks
Tuesday January 14, 2025 8:30am - 8:40am PST
Speakers 
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More →
8:40am PST
9:00am PST
Accelerating Pharmaceutical Processing Innovation Through Artificial Intelligence
Tuesday January 14, 2025 9:00am - 9:20am PST
Speakers 
Co-Founder & CEO, Phorum.AI
David Shrier is a serial entrepreneur and globally renowned advisor on digital acceleration. He has extensive technology innovation experience, having led $11 billion of growth initiatives and taken a company public on the NYSE. He runs venture studio Visionary Future, where he has...
Read More →
CEO, Veranova
Mike Riley joined Veranova as Chief Executive Officer in May 2023. Mike has over 25 years of professional experience, the majority of which has been spent in the pharmaceutical contract development and manufacturing (CDMO) industry. Prior to joining Veranova, he spent 19 years at...
Read More →
9:20am PST
Panel: Pharma’s Financial Landscape: Revenue Trends, M&A Strategies, and Patent Expirations
Tuesday January 14, 2025 9:20am - 10:00am PST
Moderators 
Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser...
Read More →GG
Senior Partner, McKinsey & Company
CF
Executive Vice President, U.S. Commercial, Teva Pharmaceuticals
Chief Strategy Officer, Astellas
As Chief Strategy Officer of Astellas Pharma, Adam Pearson plays a pivotal role in shaping the company’s corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient...
Read More →
10:00am PST
10:30am PST
Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals
Tuesday January 14, 2025 10:30am - 10:50am PST
Speakers 
President of Radiology, Bayer Pharmaceuticals
Nelson Ambrogio, President Radiology at Bayer, is a global healthcare leader with a career spanning more than 25 years with Bayer. Before joining Radiology in the beginning of 2024, he has been leading the Oncology Franchise for Bayer Pharmaceuticals in the United States, overseeing...
Read More →
10:50am PST
11:10am PST
Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape
Tuesday January 14, 2025 11:10am - 12:00pm PST
Moderators
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More → 
Chief Medical Officer, Novotech
Judith Ng-Cashin, M.D. joined Novotech in 2023 as its Chief Medical Officer. With a rich background encompassing over two decades in the international pharmaceutical, biotech, and CRO sectors, Dr. Ng-Cashin plays a pivotal role in shaping Novotech's global multi-regional later-phase...
Read More →
Chief Development Officer, Atea Pharmaceuticals
Janet is an expert in virology with a proven track record in antiviral therapeutic drug discovery and development. Janet has more than 20 years of broad and deep pharmaceutical and biopharmaceutical experience including clinical development program leadership and responsibilities...
Read More →
Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals
Eric A. Hughes, MD, PhD, is Executive Vice President, Global R&D and Chief Medical Officer at Teva, overseeing a global organization responsible for the discovery, development, registration, medical affairs and patient safety activities for Teva’s generics, biosimilar and innovative...
Read More →
Chief Medical Officer, Biohaven, Ltd
Dr. Qureshi is a board-certified neurologist and physician-scientist and is currently the Chief Medical Officer at Biohaven. He has decades-long experience in early and late-stage clinical development, translational research, and patient care. At Biohaven, he oversees a broad pipeline...
Read More →
12:00pm PST
12:20pm PST
1:20pm PST
Panel: Our AI future: A Sector-by-Sector Breakdown
Tuesday January 14, 2025 1:20pm - 2:00pm PST
Moderators 
Staff Writer, Fierce Pharma
Zoey Becker is a staff writer for Fierce Pharma. She joined the Fierce team in 2022 after interning at the Cincinnati Herald. Zoey is a graduate of Miami University, where she earned a degree in journalism as well as sociology. She currently resides in Chicago with her two goldfi...
Read More →
Senior Vice President, Digital Science & Innovation, Novo Nordisk A/S
Lars has held his current role since early 2022 and is responsible for accelerating the digital transformation of R&ED and driving scientific innovation beyond the limits of human cognition through the purpose of DSI.A long-time employee of Novo Nordisk, Lars has held a variety of...
Read More →
Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D
Sai Jasti is Head of Data Science and AI for Bayer Pharma R&D. In this capacity, Sai is responsible for driving Digital, Data and Analytics for Pharma R&D. He is passionate about helping scientists discover transformative medicines faster and driving innovation using Machine learning...
Read More →
Envisagenics, CEO and Co-Founder
Dr. Maria Luisa Pineda is the CEO and co-founder of Envisagenics. Dr. Pineda embarked on her career in STEM as a high school Intel International Science Fair winner in Miami after immigrating from Colombia in 2001. She received her doctorate from Cold Spring Harbor Laboratory School...
Read More →
2:00pm PST
2:20pm PST
2:40pm PST
3:10pm PST
Executive Interview: Sean Salmon, EVP & President, Cardiovascular, Medtronic
Tuesday January 14, 2025 3:10pm - 3:30pm PST
Speakers 
Executive Vice President and President for the Cardiovascular Portfolio, Medtronic
Sean Salmon serves as Executive Vice President and President for the Cardiovascular Portfolio.Sean is responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all Operating...
Read More →
3:30pm PST
3:50pm PST
The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies
Tuesday January 14, 2025 3:50pm - 4:30pm PST
Moderators 
Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a...
Read More →
Senior Vice President, Global Head Oncology, Research & Development, GSK
Hesham Abdullah is a seasoned physician-scientist who uniquely combines a clinician’s understanding of the impact cancer has on patients with deep expertise in identifying transformational opportunities to improve cancer treatment and care.As the head of GSK’s global oncology...
Read More →
President of the Global Oncology Business Unit and a member of the Executive Team, Takeda
Teresa Bitetti is President of the Global Oncology Business Unit and a member of the Executive Team at Takeda, where she oversees a global portfolio of therapies targeting gastrointestinal, thoracic, and hematological cancers. In this role, Teresa leads all aspects of Takeda’s multi-billion-dollar...
Read More →
President & Chief Executive Officer, Xencor
Bassil Dahiyat has been Xencor’s president and chief executive officer since the Company’s incorporation in August 1997. He is the co-founder of Xencor and co-inventor of Xencor’s breakthrough XmAb® technology. He has led the Company in creating a diverse clinical-stage portfolio...
Read More →
Senior Vice President, Biologics Engineering & Oncology Targeted Delivery, AstraZeneca
I serve as Vice President, Tumour Targeted Delivery, Early Oncology. In my current role, I lead the research group dedicated to the discovery and preclinical development of targeted cancer therapeutics and novel delivery mechanisms that selectively attack cancer cells while sparing...
Read More →
Founder and Chief Executive Officer, IO Biotech
Dr. Zocca brings more than 20 years of experience in the biotechnology field and has founded and co-founded several biotech spinouts. Her focus on translational and clinical immune oncology has led to the development of important investigational immunotherapies for a variety of cancer...
Read More →
4:30pm PST
4:50pm PST
Closing Remarks
Tuesday January 14, 2025 4:50pm - 5:00pm PST
Speakers
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More →
5:00pm PST
